ES2152394T3 - Composicion para inhalacion que contiene granulos de lactosa. - Google Patents

Composicion para inhalacion que contiene granulos de lactosa.

Info

Publication number
ES2152394T3
ES2152394T3 ES95913091T ES95913091T ES2152394T3 ES 2152394 T3 ES2152394 T3 ES 2152394T3 ES 95913091 T ES95913091 T ES 95913091T ES 95913091 T ES95913091 T ES 95913091T ES 2152394 T3 ES2152394 T3 ES 2152394T3
Authority
ES
Spain
Prior art keywords
composition
pharmaceutical composition
inhalation
containing lactose
inhalation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95913091T
Other languages
English (en)
Inventor
Gerald Wynn Hallworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10751813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2152394(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2152394T3 publication Critical patent/ES2152394T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE RELACIONA CON UNA COMPOSICION FARMACEUTICA ADECUADA PARA LA ADMINISTRACION DE MEDICAMENTOS POR INHALACION. EN PARTICULAR, LA COMPOSICION FARMACEUTICA CONTIENE PARTICULAS MICROFINAS DE MEDICAMENTO Y AL MENOS UN AGREGADO DE LACTOSA CON UN DIAMETRO DE ENTRE 10 Y 1500 MICRAS, APROXIMADAMENTE, QUE CONTIENE VARIAS PARTICULAS MICROFINAS DE LACTOSA. TAMBIEN SE DESCRIBE UN METODO PARA TRATAR TRASTORNOS RESPIRATORIOS QUE CONSISTE EN LA ADMINISTRACION POR INHALACION DE UNA CANTIDAD EFICAZ DE MEDICAMENTO SELECCIONADO ENTRE UN GRUPO FORMADO POR ANTIALERGICOS, BRONCODILATADORES, ESTEROIDES ANTI-INFLAMATORIOS Y MEZCLAS DE ESTOS AGENTES EN LA COMPOSICION FARMACEUTICA DESCRITA.
ES95913091T 1994-03-15 1995-03-13 Composicion para inhalacion que contiene granulos de lactosa. Expired - Lifetime ES2152394T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9404945A GB9404945D0 (en) 1994-03-15 1994-03-15 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES2152394T3 true ES2152394T3 (es) 2001-02-01

Family

ID=10751813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95913091T Expired - Lifetime ES2152394T3 (es) 1994-03-15 1995-03-13 Composicion para inhalacion que contiene granulos de lactosa.

Country Status (12)

Country Link
US (2) US6183782B1 (es)
EP (1) EP0750492B1 (es)
AT (1) ATE196989T1 (es)
AU (1) AU2068995A (es)
DE (1) DE69519157T2 (es)
DK (1) DK0750492T3 (es)
ES (1) ES2152394T3 (es)
GB (1) GB9404945D0 (es)
GR (1) GR3034845T3 (es)
PT (1) PT750492E (es)
WO (1) WO1995024889A1 (es)
ZA (1) ZA952049B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
SE9700135D0 (sv) † 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
EP0876814A1 (en) * 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
DE60133203T3 (de) * 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
PL200063B1 (pl) * 2000-10-12 2008-12-31 Boehringer Ingelheim Pharma Nowe proszki do inhalacji zawierające tiotropium
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2002085296A2 (en) * 2001-04-24 2002-10-31 Epigenesis Pharmaceuticals, Inc. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
JP2005530725A (ja) * 2002-04-12 2005-10-13 カンピナ・ネーデルラント・ホールディング・ベスローテン・フェンノートシャップ ドライパウダー吸入製剤において使用する賦形剤
DK1531794T3 (en) * 2002-06-28 2017-08-28 Civitas Therapeutics Inc INHALABLE EPINEPHRIN
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
AU2004272077A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
RU2007133547A (ru) 2005-02-10 2009-03-20 Глаксо Груп Лимитед (GB) Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
EP1944018A1 (en) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation
DK2425820T3 (en) * 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
EP1964564A1 (en) * 2007-04-19 2008-09-03 LAB International SRL Breakthrough Pain Management
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
TR200909791A2 (tr) * 2009-12-25 2011-07-21 B�Lg�� Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2821062A1 (en) 2013-07-01 2015-01-07 Arven Ilac Sanayi Ve Ticaret A.S. Novel dry powder inhaler formulations
US10583085B2 (en) * 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
ES2916413T3 (es) 2018-04-16 2022-06-30 Ioulia Tseti Una composición farmacéutica en polvo seco para inhalación que comprende una hormona tiroidea
CN114514020A (zh) 2019-09-24 2022-05-17 奇斯药制品公司 用于吸入用干粉制剂的新型载体颗粒

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB398631A (en) 1932-07-28 1933-09-21 Fredk Thomas & Company Ltd Improvements in and connected with lamp-shades
US2897119A (en) * 1957-11-12 1959-07-28 Camp Sea Food Company Inc Van Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
US3341415A (en) * 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787066A (fr) 1971-08-03 1973-02-01 Beecham Group Ltd Compositions pharmaceutiques comprenant de la 2-nitroindane-1,3-dione
GB1410588A (en) 1971-08-10 1975-10-22 Fisons Ltd Composition
GB1478020A (en) 1973-09-14 1977-06-29 Beecham Group Ltd Composition for the treatment of asthma
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB1571629A (en) 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
DE3326089A1 (de) 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
ATE94801T1 (de) 1990-01-29 1993-10-15 Ciba Geigy Ag Verfahren und vorrichtung zur dosierung eines feinkoernigen pulvers.
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
SK283569B6 (sk) * 1993-10-01 2003-09-11 Astra Aktiebolag Spôsob spracovania jemne deleného práškového liečiva, zariadenie na vykonávanie tohto spôsobu a aglomeráty vyrobené týmto spôsobom
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物

Also Published As

Publication number Publication date
WO1995024889A1 (en) 1995-09-21
GR3034845T3 (en) 2001-02-28
DE69519157D1 (de) 2000-11-23
DK0750492T3 (da) 2000-12-18
GB9404945D0 (en) 1994-04-27
PT750492E (pt) 2001-03-30
US6183782B1 (en) 2001-02-06
DE69519157T2 (de) 2001-08-09
ZA952049B (en) 1995-12-21
EP0750492A1 (en) 1997-01-02
ATE196989T1 (de) 2000-11-15
US6955824B1 (en) 2005-10-18
AU2068995A (en) 1995-10-03
EP0750492B1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
ATE196989T1 (de) Inhalationszusammensetzungmit lactosegranulate
AU4260496A (en) Propellant mixture for aerosol formulation
SE9701956D0 (sv) New composition of matter
GB9426252D0 (en) Pharmaceutical composition
MX9605650A (es) Formulaciones de propionato de fluticasona.
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
OA09868A (en) Non-chorofluorocarbon aerosol formulation.
WO2000024362A3 (en) Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
GEP19991820B (en) Pharmaceutical Aerosol Formulation
IE821453L (en) Oral dipyridamole preparations
HUT77927A (hu) Nebivolol-származékok alkalmazása antiatherogén hatású gyógyászati készítmények előállítására és e vegyületeket tartalmazó kombinációs gyógyászati készítmények
PH27594A (en) Medicaments for the treatment of asthma and other respiratory disorders
ES2133130A1 (es) Nueva formulacion de budesonida, su uso y recipiente que la contiene.
CA2150185A1 (en) Pharmaceutical composition for the treatment of stoma-peripheral inflammation
EP0401903A3 (en) The use of vanilloids for the treatment of respiratory diseases or disorders
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
CA2158036A1 (en) 3,4-Diarylchromans for Treatment of Dermatitis
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
WO1996005836A3 (en) Methods of treating cold symptoms using pentoxifylline
EP1101493A3 (en) New combination of formoterol and budesonide
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 750492

Country of ref document: ES